These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 13703668)
1. Further studies on corticotropin releasing factor (CRF); corticotropin releasing activity of synthetic peptides. de GARILHE M; GROS C; PORATH J; LINDNER EB Experientia; 1960 Sep; 16():414-5. PubMed ID: 13703668 [No Abstract] [Full Text] [Related]
2. On the in vitro corticotropin releasing factor (CRF) activity of the heptapeptide: methionyl-glutaminyl-histidyl-phenylalanyl-arginyl-tryptophyl-glycine. PRIVAT DE GARILHE M; GROS C Experientia; 1962 Feb; 18():92-3. PubMed ID: 14488845 [No Abstract] [Full Text] [Related]
3. A semi-automated in vitro assay for CRF: activities of peptides related to oxytocin and vasopressin. Pearlmutter AF; Rapino E; Saffran M Neuroendocrinology; 1974; 15(2):106-19. PubMed ID: 4368352 [No Abstract] [Full Text] [Related]
4. Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor. GUILLEMIN R; SCHALLY AV Endocrinology; 1959 Oct; 65():555-62. PubMed ID: 13830170 [No Abstract] [Full Text] [Related]
5. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin. Spinedi E; Negro-Vilar A Neuroendocrinology; 1983 Dec; 37(6):446-53. PubMed ID: 6318148 [TBL] [Abstract][Full Text] [Related]
6. The antidiuretic- and ACTH-releasing effect of various octapeptides. DE WIED D; SIDERIUS P; MIRSKY IA Arch Int Pharmacodyn Ther; 1961; 133():50-7. PubMed ID: 13884599 [No Abstract] [Full Text] [Related]
7. Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides. Mazur AW; Wang F; Tscheiner M; Donnelly E; Isfort RJ J Med Chem; 2004 Jun; 47(13):3450-4. PubMed ID: 15189041 [TBL] [Abstract][Full Text] [Related]
8. Release of corticotropin and corticotropin-releasing factors from rat posterior pituitary in vitro. Bény JL; Baertschi AJ Neuroendocrinology; 1980; 30(2):108-12. PubMed ID: 6243758 [TBL] [Abstract][Full Text] [Related]
9. Involvement of corticotropin-releasing factor and adrenocorticotropic hormone in the ovarian maturation, seawater acclimation, and induced spawning of Liza ramada. Mousa SA; Mousa MA Gen Comp Endocrinol; 2006 Apr; 146(2):167-79. PubMed ID: 16376890 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs. Knepel W; Homolka L; Vlaskovska M; Nutto D Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345 [TBL] [Abstract][Full Text] [Related]
11. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Gulyas J; Rivier C; Perrin M; Koerber SC; Sutton S; Corrigan A; Lahrichi SL; Craig AG; Vale W; Rivier J Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10575-9. PubMed ID: 7479843 [TBL] [Abstract][Full Text] [Related]
12. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats. Murakami K; Hashimoto K; Ota Z Neuroendocrinology; 1984 Jul; 39(1):49-53. PubMed ID: 6087183 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. Liu JH; Muse K; Contreras P; Gibbs D; Vale W; Rivier J; Yen SS J Clin Endocrinol Metab; 1983 Nov; 57(5):1087-9. PubMed ID: 6311862 [TBL] [Abstract][Full Text] [Related]
14. ACTH releasing factor active in the guinea pig. SIDEMAN M; SOBEL H Proc Soc Exp Biol Med; 1960 Feb; 103():274-7. PubMed ID: 14446415 [No Abstract] [Full Text] [Related]
15. New class of corticotropin-releasing factor (CRF) antagonists: small peptides having high binding affinity for CRF receptor. Yamada Y; Mizutani K; Mizusawa Y; Hantani Y; Tanaka M; Tanaka Y; Tomimoto M; Sugawara M; Imai N; Yamada H; Okajima N; Haruta J J Med Chem; 2004 Feb; 47(5):1075-8. PubMed ID: 14971886 [TBL] [Abstract][Full Text] [Related]
16. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Westendorf JM; Schonbrunn A Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986 [TBL] [Abstract][Full Text] [Related]
17. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease. Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123 [TBL] [Abstract][Full Text] [Related]
18. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Vale W; Vaughan J; Smith M; Yamamoto G; Rivier J; Rivier C Endocrinology; 1983 Sep; 113(3):1121-31. PubMed ID: 6307665 [TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Sirinathsinghji DJ; Rees LH; Rivier J; Vale W Nature; 1983 Sep 15-21; 305(5931):232-5. PubMed ID: 6310414 [TBL] [Abstract][Full Text] [Related]
20. Evidence for the existence of two corticotrophin-releasing factors, alpha and beta. SCHALLY AV; ANDERSEN RN; LIPSCOMB HS; LONG JM; GUILLEMIN R Nature; 1960 Dec; 188():192-3. PubMed ID: 13747238 [No Abstract] [Full Text] [Related] [Next] [New Search]